Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01712815 · ClinicalTrials.gov registry record · NA
PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer
A NA study, sponsored by University of Southern California.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01712815 is a NA study that was terminated before completion, run by University of Southern California. The registered enrollment target is 12 participants.
The verdict
NCT01712815, a NA study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This phase I trial studies the side effects of positron emission tomography (PET)/computed tomography (CT) in evaluating response to chemotherapy in patients with breast cancer. Comparing results of diagnostic procedures done before, during, and after chemotherapy may help doctors predict a patient's response to treatment and help plan the best treatment.
Interventions
- OTHER laboratory biomarker analysis
- OTHER questionnaire administration
- OTHER pharmacological study
- PROCEDURE positron emission tomography/computed tomography
- RADIATION fluorine F 18-clevudine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2013-11-22 |
| Est. Completion | 2022-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01712815
The ClinicalTrials.gov registry entry for NCT01712815 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which laboratory biomarker analysis is the first listed.
NCT01712815 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01712815 about?
NCT01712815 is a clinical study titled "PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer". This phase I trial studies the side effects of positron emission tomography (PET)/computed tomography (CT) in evaluating response to chemotherapy in patients with breast cancer. Comparing results of diagnostic procedures done before, during, and after chemotherapy may help doctors predict a patient'...
What is the current status of trial NCT01712815?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2013-11-22. Estimated completion is 2022-11-01.
What interventions are being tested in trial NCT01712815?
The interventions under investigation include: laboratory biomarker analysis (OTHER), questionnaire administration (OTHER), pharmacological study (OTHER), positron emission tomography/computed tomography (PROCEDURE), fluorine F 18-clevudine (RADIATION).
Who is sponsoring clinical trial NCT01712815?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.